Allied Pharma Capital
Insurance · Lobbying Client
C
Influence Score
47/100
Moderate Influence
$1.6M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Allied Pharma Capital reported $1.6 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Insurance, Health Issues, Taxation. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of State
Dept of Interior
Dept of Health & Human Services
Dept of Agriculture
Dept of Energy
Dept of Transportation
Federal Energy Regulatory Commission
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | K&L Gates LLP | TAXINSGOV+2 | 1 | $80K |
| 2020 Apr-Jun | Akin Gump LLP | TAXGOVAPP | 1 | $57K |
| 2020 Jul-Sep | BGR Group LLP | GOVINSAPP | 1 | $81K |
| 2020 Oct-Dec | Brownstein Hyatt LLP | GOVHCRINS+1 | 1 | $68K |
| 2021 Jan-Mar | Covington & Burling LLP | ACCGOVAPP+2 | 1 | $89K |
| 2021 Apr-Jun | BGR Group LLP | HCRTAXACC+1 | 1 | $74K |
| 2021 Jul-Sep | Holland & Knight LLP | GOV | 1 | $72K |
| 2021 Oct-Dec | Squire Patton Boggs LLP | ACCHCRAPP+1 | 1 | $83K |